Short Float History | News | Indicators | Short Stats | Earnings History | Technical Averages | HRTX Yahoo Finance Page

HRTX Heron Therapeutics Inc.

$39.6 +2.19%

687,243 Shares Traded
785,700 Average Volume (last 30 days)

as of August 14, 2018 EST IEX Real-Time Price

Click Here to Short Float History Versus Price & Peer Short Floats

Free Newsletter Sign Up

News

08-08-2018
Heron Therapeutics beats by $0.16, beats on revenue (SeekingAlpha)
08-08-2018
Heron Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2018 and Recent Corporate Progress (PR Newswire)


Short Pain Metrics

Approximate Amount of Money Shorts Have Lost on the Day: $6.56 million
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-114.05%
If Intiated One Month Ago, Shorts Have Realized a Return of:-2.19%
If Initiated Five Days ago, Shorts Have Realized a Return of:-0.13%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points.

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bullish
50 Day Moving Average Indicator Bullish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 10.13%
Short Interest7.72 million
Float76.17 million
Short Ratio9.25
Market Cap$3.08 billion
Market Maker ActivityDaily Short Volume

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 90.2%
Insider Percent2%

Earnings Stats

PE Ratio -12.34
Dividend Yield 0%
Peer EarningsEarnings Calendar

Earnings History For HRTX

Earnings DateQuarterConsensus EPSActual EPSEPS Surprise
2018-08-08 Q2 2018-0.69 (6 Estimates) -0.540.15
2018-05-10 Q1 2018-0.82 (6 Estimates) -0.810.01
2018-02-27 Q4 2017-0.78 (7 Estimates) -1.09-0.31
2017-11-06 Q3 2017-0.87 (6 Estimates) -0.770.1

Technicals

200 Day Moving Average $26.54
50 Day Moving Average $36.72
52 Week High $42.9
52 Week Low $14.4

Back to the Top

Data provided for free by IEX. Questions? Read the FAQ